No Detail Found!

Production of goat pox virus vaccine from a live attenuated goat pox virus strain

Author(s)
A. Hussain Center for Advanced Studies in Vaccinology & Biotechnology, University of Balochistan, Quetta, PAKISTAN
S. Ahmed Center for Advanced Studies in Vaccinology & Biotechnology, University of Balochistan, Quetta, PAKISTAN
F. Abbas Veterinary Research Institute, Quetta, PAKISTAN
F. A. Khan Veterinary Research Institute, Quetta, PAKISTAN
M. Ahmed Veterinary Research Institute, Quetta, PAKISTAN
M. Z. Ahmed Veterinary Research Institute, Quetta, PAKISTAN
M. A. Attique Veterinary Research Institute, Quetta, PAKISTAN
A. Wadood Veterinary Research Institute, Quetta, PAKISTAN
M. K. Taj Veterinary Research Institute, Quetta, PAKISTAN
Abstract
Kid kidney cells form less than 2 months of age were grown, 80% confluent monolayers were obtained after 10-12 days.   Live attenuated goat pox virus vaccine (Gorgan 55, Iranian) was used to infect the confluent monolayers.   Eighty percent cytopethic effect (CPE) was obtained on day 5 of virus inoculation.  TCID50 calculated for the pool virus was 10 5.5/ ml.  Vaccine was found free from any bacterial and mycoplasma contamination. All mice and guinea pigs were found healthy after 21days post vaccinal administration.  Vaccinated goats challenged after 14 days with 1 ml of virulent goat pox virus (TCID50 104.5/ml) did not show any unwanted reaction while controls challenged with 1 ml of virulent goat pox virus (TCID50 10 3.5/ml)  showed pox lesions and rise in body temperature. The main objective of this study was to produce and study the efficacy of this vaccine.
Publication Details
Page(s) 315-316
DOI DOI not available
Published Journal: Journal of Animal and Plant sciences, Volume: 20, Issue: 4, Year: 2010

Request the full text from PASTIC

0

Citations

0

Downloads

99

Views